← Back to Search

Acupuncture for High Blood Pressure (Amp-HTN Trial)

Phase 2
Waitlist Available
Led By Jeremy M Kellawan, PhD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up prior to enrolment
Awards & highlights

Amp-HTN Trial Summary

This trial will investigate whether acupuncture treatment can help improve brain health in patients with hypertension by looking at how it affects cerebrovascular responses during exercise.

Eligible Conditions
  • High Blood Pressure

Amp-HTN Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 min of moderate exercise
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 min of moderate exercise for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cerebrovascular Conductance Index
Mean Arterial Pressure
Middle cerebral artery blood velocity
Secondary outcome measures
End-tidal CO2
Heart Rate Variability
Oxygen Uptake
+6 more

Side effects data

From 2013 Phase 1 & 2 trial • 104 Patients • NCT01305811
2%
Serious unexpected
2%
Pain on needling
100%
80%
60%
40%
20%
0%
Study treatment Arm
Bi-Weekly Acupuncture
Wait List

Amp-HTN Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: AcupunctureExperimental Treatment1 Intervention
In a supine position with a cardboard blocking view of their legs, patients will have six, 0.25*40mm sterilized stainless steel acupuncture needles (Dongbang Acupuncture, Inc., Seoul, South Korea) inserted into six acupoints (sites ST36, LV3, KI2, bilaterally) on their lower legs. After insertion, the needles will be stimulated at 2-4Hz, 10s at each point (1min total), immediately after insertion, 5min, 10min, 15min and just before removal. After which the needles will be removed.
Group II: Sham AcupuncturePlacebo Group1 Intervention
Specially designed Sham acupuncture needles that are not actually penetrate the skin and activate the acupoint will be used in an identical procedure to RA. The patient would be able to feel light pressure at the site.

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
455 Previous Clinical Trials
97,610 Total Patients Enrolled
Jeremy M Kellawan, PhDPrincipal InvestigatorUniversity of Oklahoma
1 Previous Clinical Trials
30 Total Patients Enrolled

Media Library

Acupuncture Clinical Trial Eligibility Overview. Trial Name: NCT04346511 — Phase 2
High Blood Pressure Research Study Groups: Acupuncture, Sham Acupuncture
High Blood Pressure Clinical Trial 2023: Acupuncture Highlights & Side Effects. Trial Name: NCT04346511 — Phase 2
Acupuncture 2023 Treatment Timeline for Medical Study. Trial Name: NCT04346511 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a risk of serious injury with Acupuncture?

"There is some data supporting the safety of acupuncture, but none suggesting that it is an effective treatment. Therefore, it received a score of 2."

Answered by AI

Are people with the qualifying condition still able to join this trial?

"The listed clinical trial is not currently looking for patients, as the last edit was made over 8 months ago. However, there are 785 other trials with similar treatments that may be of interest."

Answered by AI

What are the primary objectives of this experiment?

"The main goal of this 5 minute clinical trial during moderate exercise will be to assess the Cerebrovascular Conductance Index. Other measures that will be taken include End-tidal CO2, blood high density lipoprotein levels, and Heart Rate Variability."

Answered by AI

Could I potentially qualify to be a part of this research?

"Qualified patients that wish to enroll in this clinical trial must have hypertension and be between 18-65 years old. Currently, the study is looking for 60 individuals to participate."

Answered by AI

Are the patients in this trial all over 18 years old?

"The age range that is able to enroll in this trial are patients between 18-65 years old."

Answered by AI

Who else is applying?

What site did they apply to?
Department of Health and Exercise Science
What portion of applicants met pre-screening criteria?
Met criteria
~0 spots leftby Apr 2025